Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$4.3B |
| 2 |
S&P Global
SPGI
|
+$3.68B |
| 3 |
Tesla
TSLA
|
+$2.54B |
| 4 |
Mastercard
MA
|
+$2.11B |
| 5 |
Constellation Energy
CEG
|
+$1.87B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$5.72B |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$5.19B |
| 3 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$1.63B |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$1.59B |
| 5 |
Baidu
BIDU
|
+$1.35B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.03% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.84% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Industrials | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4151
Cellectar Biosciences
CLRB
$20.5M
| $1.21M | ﹤0.01% |
5,846
-692
| -11% | -$121K |
|
4152
Soligenix
SNGX
$5.81M
| $1.2M | ﹤0.01% |
6,853
| – | – |
|
4153
Fuel Tech
FTEK
$43.7M
| $1.2M | ﹤0.01% |
824,923
-35,746
| -4% | -$45.7K |
|
4154
Imunon
IMNN
$6.77M
| $1.19M | ﹤0.01% |
18,013
-1,851
| -9% | -$145K |
|
4155
Oxbridge Re Holdings
OXBR
$10.8M
| $1.19M | ﹤0.01% |
217,103
| – | – |
|
|
ADIL
4156
Adial Pharmaceuticals
ADIL
$8.71M
| $1.19M | ﹤0.01% |
945
| – | – |
|
|
OMQS
4157
DELISTED
OMNIQ Corp. Common Stock
OMQS
| $1.18M | ﹤0.01% |
175,600
| – | – |
|
|
FAT
4158
DELISTED
FAT Brands
FAT
| $1.17M | ﹤0.01% |
279,746
| – | – |
|
4159
Air T
AIRT
$86.1M
| $1.16M | ﹤0.01% |
51,047
-643
| -1% | -$15.6K |
|
4160
Bank Of The James
BOTJ
$124M
| $1.16M | ﹤0.01% |
78,102
| – | – |
|
4161
Rezolute
RZLT
$452M
| $1.16M | ﹤0.01% |
343,739
+10,500
| +3% | +$40.4K |
|
|
ZSAN
4162
DELISTED
Zosano Pharma Corporation
ZSAN
| $1.16M | ﹤0.01% |
147,112
+23,380
| +19% | +$257K |
|
|
ISO
4163
DELISTED
IsoPlexis Corporation Common Stock
ISO
| $1.15M | ﹤0.01% |
335,282
+32,114
| +11% | +$186K |
|
|
RVPH
4164
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $1.15M | ﹤0.01% |
23,275
-1,445
| -6% | -$57.7K |
|
4165
X4 Pharmaceuticals
XFOR
$460M
| $1.14M | ﹤0.01% |
21,773
-9,335
| -30% | -$535K |
|
4166
Caesarstone
CSTE
$79.5M
| $1.13M | ﹤0.01% |
107,753
+2,068
| +2% | +$24.5K |
|
4167
Stratasys
SSYS
$774M
| $1.13M | ﹤0.01% |
44,437
+200
| +0.5% | +$4.82K |
|
4168
AN2 Therapeutics
ANTX
$214M
| $1.13M | ﹤0.01% |
+74,733
| New | +$1.13M |
|
4169
Processa Pharmaceuticals
PCSA
$8.61M
| $1.13M | ﹤0.01% |
747
| – | – |
|
|
TESS
4170
DELISTED
Tessco Technologies Inc
TESS
| $1.12M | ﹤0.01% |
185,302
-107,789
| -37% | -$645K |
|
4171
Astrotech Corp
ASTC
$17.8M
| $1.12M | ﹤0.01% |
51,692
-2,658
| -5% | -$54.5K |
|
|
AUTO
4172
DELISTED
AutoWeb, Inc. Common Stock
AUTO
| $1.11M | ﹤0.01% |
481,501
| – | – |
|
4173
Arcadia Biosciences
RKDA
$1.52M
| $1.1M | ﹤0.01% |
19,768
| – | – |
|
4174
Canterbury Park Holding Corp
CPHC
$80M
| $1.1M | ﹤0.01% |
48,887
+10,268
| +27% | +$200K |
|
|
RGLS
4175
DELISTED
Regulus Therapeutics
RGLS
| $1.1M | ﹤0.01% |
367,833
+64,812
| +21% | +$169K |
|
Similar funds
Vanguard Group's Q1 2022 Portfolio in Review
As of Q1 2022, Vanguard Group held 4,704 positions worth $4.23T, down 4% from $4.4T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Trading was light in Q1 2022: portfolio turnover was 3.2%. Vanguard Group opened 70 new positions and exited 79, leaving the 4,704-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
- Vanguard Group's largest Q1 2022 buy was Constellation Energy: 38,414,517 shares worth $2.16B.
- Vanguard Group added most to Advanced Micro Devices in Q1 2022, an estimated $4.3B increase.
- Vanguard Group's biggest Q1 2022 reduction was Baidu, cutting an estimated $1.35B.
- Vanguard Group fully exited Xilinx Inc in Q1 2022, selling an estimated $5.72B.
- Vanguard Group's ten largest holdings make up 21% of its $4.23T portfolio in Q1 2022.
- Vanguard Group opened 70 new positions and closed 79 in Q1 2022.
- Vanguard Group's portfolio value fell 4% quarter-over-quarter to $4.23T.
Based on Vanguard Group's 13F filing for Q1 2022, filed 13 May 2022.